These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


54 related items for PubMed ID: 3629790

  • 1. [Hemodynamic changes and late vascular complications after thrombosis of the retinal veins].
    Machekhin VA, Branchevskaia SIa, Stebnev SD.
    Vestn Oftalmol; 1987; 103(3):41-5. PubMed ID: 3629790
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Occlusion of the central retinal vein in young adults: risk factors and visual prognosis].
    Snyers B, Serckx JP.
    Bull Soc Belge Ophtalmol; 1993; 250():51-8. PubMed ID: 7952362
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High prevalence of resistance to APC in young patients with retinal vein occlusion.
    Kuhli C, Hattenbach LO, Scharrer I, Koch F, Ohrloff C.
    Graefes Arch Clin Exp Ophthalmol; 2002 Mar; 240(3):163-8. PubMed ID: 11935272
    [Abstract] [Full Text] [Related]

  • 10. Intravitreal tissue plasminogen activator for the treatment of central retinal vein occlusion.
    Weizer JS, Fekrat S.
    Ophthalmic Surg Lasers Imaging; 2003 Mar; 34(4):350-2. PubMed ID: 12875471
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Results of the use of ticlid in the treatment of patients with post-thrombotic retinopathy].
    Davydova NG, Mukha AI, Annamedov G.
    Vestn Oftalmol; 1992 Mar; 108(2):22-4. PubMed ID: 1529486
    [Abstract] [Full Text] [Related]

  • 13. Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion.
    Degenring RF, Kamppeter B, Kreissig I, Jonas JB.
    Acta Ophthalmol Scand; 2003 Oct; 81(5):548-50. PubMed ID: 14510813
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Combined occlusion of the central retinal artery and vein.
    Iijima H, Tsumura T.
    Jpn J Ophthalmol; 1994 Oct; 38(2):202-7. PubMed ID: 7967214
    [Abstract] [Full Text] [Related]

  • 17. [Radial optic neurotomy for ischemic central retinal vein occlusion].
    Lommatzsch A, Heimes B, Gutfleisch M, Spital G, Trieschmann M, Pauleikhoff D.
    Klin Monbl Augenheilkd; 2007 Oct; 224(10):763-9. PubMed ID: 17952819
    [Abstract] [Full Text] [Related]

  • 18. [Measurement of macular edema in retinal vein occlusion using optical coherence tomography and its visual prognosis].
    Zhang HR, Wang X, Lu XR, Yang YF, Liu F.
    Zhonghua Yan Ke Za Zhi; 2005 Oct; 41(10):910-6. PubMed ID: 16271177
    [Abstract] [Full Text] [Related]

  • 19. Electroretinographic findings versus fluorescein angiographic appearance of the retina in patients with ischaemic and non-ischaemic central retinal vein occlusion.
    Mangelschots E, Leys A, Spileers W.
    Bull Soc Belge Ophtalmol; 1995 Oct; 255():9-16. PubMed ID: 7496581
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 3.